IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $695 | +6.4% | 72,107 | +17.5% | 0.00% | – |
Q2 2023 | $653 | +3.7% | 61,345 | +2.6% | 0.00% | – |
Q1 2023 | $630 | -45.1% | 59,794 | -35.5% | 0.00% | – |
Q4 2022 | $1,148 | -99.9% | 92,695 | -7.7% | 0.00% | – |
Q3 2022 | $1,041,000 | -1.2% | 100,389 | +9.8% | 0.00% | – |
Q2 2022 | $1,054,000 | -8.5% | 91,397 | -0.2% | 0.00% | – |
Q1 2022 | $1,152,000 | +1.2% | 91,550 | -6.2% | 0.00% | – |
Q4 2021 | $1,138,000 | -28.7% | 97,617 | -20.1% | 0.00% | – |
Q3 2021 | $1,595,000 | -6.7% | 122,145 | -8.1% | 0.00% | – |
Q2 2021 | $1,710,000 | +1.4% | 132,845 | -12.0% | 0.00% | – |
Q1 2021 | $1,687,000 | -14.4% | 150,914 | -12.8% | 0.00% | – |
Q4 2020 | $1,971,000 | -77.2% | 173,074 | -82.0% | 0.00% | -100.0% |
Q3 2020 | $8,637,000 | -18.3% | 960,158 | -6.3% | 0.00% | 0.0% |
Q2 2020 | $10,571,000 | -14.6% | 1,024,292 | -16.5% | 0.00% | -50.0% |
Q1 2020 | $12,372,000 | -20.3% | 1,226,123 | +5.1% | 0.00% | 0.0% |
Q4 2019 | $15,530,000 | +54.5% | 1,166,815 | -0.3% | 0.00% | +100.0% |
Q3 2019 | $10,052,000 | -20.4% | 1,170,882 | +1.5% | 0.00% | -50.0% |
Q2 2019 | $12,625,000 | -57.6% | 1,154,044 | -47.6% | 0.00% | -50.0% |
Q1 2019 | $29,791,000 | -7.0% | 2,201,880 | -28.8% | 0.00% | -20.0% |
Q4 2018 | $32,025,000 | -80.6% | 3,091,185 | -65.4% | 0.01% | -79.2% |
Q3 2018 | $164,737,000 | -22.9% | 8,923,985 | -20.1% | 0.02% | -27.3% |
Q2 2018 | $213,543,000 | +13.3% | 11,168,591 | -8.5% | 0.03% | +10.0% |
Q1 2018 | $188,407,000 | -29.6% | 12,210,451 | -31.6% | 0.03% | -30.2% |
Q4 2017 | $267,777,000 | +0.1% | 17,863,732 | +5.3% | 0.04% | -6.5% |
Q3 2017 | $267,467,000 | -13.8% | 16,960,490 | +3.3% | 0.05% | -17.9% |
Q2 2017 | $310,124,000 | +11.5% | 16,426,065 | +0.7% | 0.06% | +7.7% |
Q1 2017 | $278,190,000 | +25.6% | 16,306,543 | +12.5% | 0.05% | +18.2% |
Q4 2016 | $221,538,000 | +59.1% | 14,489,073 | +65.2% | 0.04% | +57.1% |
Q3 2016 | $139,282,000 | +42.0% | 8,770,893 | +16.9% | 0.03% | +33.3% |
Q2 2016 | $98,083,000 | +33.7% | 7,501,583 | +11.9% | 0.02% | +31.2% |
Q1 2016 | $73,355,000 | +23.7% | 6,705,210 | +31.0% | 0.02% | +33.3% |
Q4 2015 | $59,318,000 | +11.0% | 5,118,010 | -0.2% | 0.01% | 0.0% |
Q3 2015 | $53,447,000 | -14.6% | 5,129,310 | -1.2% | 0.01% | -7.7% |
Q2 2015 | $62,588,000 | +48.7% | 5,189,700 | +97.3% | 0.01% | +44.4% |
Q1 2015 | $42,084,000 | +183.0% | 2,630,248 | +171.0% | 0.01% | +200.0% |
Q4 2014 | $14,870,000 | -19.0% | 970,620 | -31.5% | 0.00% | -25.0% |
Q3 2014 | $18,353,000 | -17.2% | 1,416,701 | -2.1% | 0.00% | -20.0% |
Q2 2014 | $22,178,000 | -2.5% | 1,446,701 | -21.7% | 0.01% | 0.0% |
Q1 2014 | $22,752,000 | -50.2% | 1,846,736 | -53.1% | 0.01% | 0.0% |
Q4 2013 | $45,730,000 | +126.0% | 3,938,908 | +130.7% | 0.01% | 0.0% |
Q3 2013 | $20,233,000 | -36.9% | 1,707,400 | -47.0% | 0.01% | +25.0% |
Q2 2013 | $32,080,000 | – | 3,224,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
13D Management LLC | 650,455 | $8,371,000 | 2.88% |
BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |